Martin Tami Tillotson 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Restricted Stock Units
2023-02-23+5,000→ 5,000 total→ Common Stock (5,000 underlying) - Award
Employee Stock Option (Right to Buy)
2023-02-23+20,000→ 20,000 totalExercise: $38.60Exp: 2033-02-23→ Common Stock (20,000 underlying)
Holdings
- 90,323
Common Stock
Footnotes (3)
- [F1]The option vests in four equal annual installments beginning on February 23, 2024.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024.